Abstract
Background
Spontaneous subarachnoid hemorrhage (SSAH) is associated with significant morbidity and mortality. Pathophysiological processes following initial bleeding are complex and not fully understood. In this study, we aimed to determine whether a low level of ionized calcium (Ca++), an essential cofactor in the coagulation cascade and other cellular processes, is associated with adverse neurological outcome, development of early hydrocephalus, and symptomatic vasospasm among patients with SSAH.
Methods
This was a retrospective single-center cohort study of all patients admitted for SSAH between January 1, 2009, and April 31, 2020. The primary outcome was an unfavorable neurological status at discharge, defined as a modified Rankin Scale score greater than or equal to 3. Secondary outcomes were the development of early hydrocephalus and symptomatic vasospasm. Multivariable logistic regression was performed to determine whether Ca++ was an independent predictor of these outcomes.
Results
A total of 255 patients were included in the final analysis. Hypocalcemia, older age, admission Glasgow Coma Scale (GCS) score, and admission Hunt–Hess classification scale (H&H) grades IV and V were independently associated with unfavorable neurological outcome, with adjusted odds ratios (ORs) of 1.93 (95% confidence interval [CI] 1.1–3.4; p = 0.02) for each 0.1 mmol L−1 decrease in the Ca++ level, 1.04 (95% CI 1.01–1.08; p = 0.02) for each year increase, 0.82 (95% CI 0.68–0.99; p = 0.04), and 6.29 (95% CI 1.14–34.6; p = 0.03), respectively. Risk factors for the development of hydrocephalus were hypocalcemia and GCS score, with ORs of 1.85 (95% CI 1.26–2.71; p = 0.002) for each 0.1 mmol L−1 decrease in the Ca++ level and 0.83 (95% CI 0.73–0.94; p = 0.005), respectively. Ca++ was not associated with symptomatic vasospasm (OR 1.04 [95% CI 0.76–1.41]; p = 0.81). Among patients with admission H&H grade I–III bleeding, hypocalcemia was independently associated with unfavorable neurological outcome at discharge, with an adjusted OR of 1.99 (95% CI 1.03–3.84; p = 0.04) for each 0.1 mmol L−1 decrease in the Ca++ level. Hypocalcemia was also an independent risk factor for the development of early hydrocephalus, with an adjusted OR of 2.95 (95% CI 1.49–5.84; p = 0.002) for each 0.1 mmol L−1 decrease in the Ca++ level. Ca++ was not associated with symptomatic vasospasm. No association was found between Ca++ and predefined outcomes among patients with admission H&H grade IV and V bleeding.
Conclusions
Our study shows that hypocalcemia is associated with worse neurological outcome at discharge and development of early hydrocephalus in endovascularly treated patients with SSAH. Potential mechanisms include calcium-induced coagulopathy and higher blood pressure. Trials are needed to assess whether correction of hypocalcemia will lead to improved outcomes.
Similar content being viewed by others
References
van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306–18.
Linn FHH, Rinkel GJ, Algra A, van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke. 1996;27(4):625–9.
Lantigua H, Ortega-Gutierrez S, Schmidt JM, Lee K, Badjatia N, Agarwal S, et al. Subarachnoid hemorrhage: Who dies, and why? Crit Care. 2015;19(1):309.
Johnston SC, Selvin S, Gress DR. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):1413–8.
Morotti A, Charidimou A, Phuah C-L, Jessel MJ, Schwab K, Ayres AM, et al. Association between serum calcium level and extent of bleeding in patients with intracerebral hemorrhage. JAMA Neurol. 2016;73(11):1285–90.
Inoue Y, Miyashita F, Toyoda K, Minematsu K. Low serum calcium levels contribute to larger hematoma volume in acute intracerebral hemorrhage. Stroke. 2013;44(7):2004–6.
Tu L, Liu X, Li T, Yang X, Ren Y, Zhang Q, et al. Admission serum calcium level as a prognostic marker for intracerebral hemorrhage. Neurocrit Care. 2019;30(1):81–7.
Guo Y, Yan S, Zhang S, Zhang X, Chen Q, Liu K, et al. Lower serum calcium level is associated with hemorrhagic transformation after thrombolysis. Stroke. 2015;46(5):1359–61.
Britz GW, Sviri GE. Vertebrobasilar vasospasm after aneurysmal subarachnoid hemorrhage: review. J Neurol Stroke. 2018;8(1):00278.
Kaji AH, Schriger D, Green S. Looking through the retrospectoscope: reducing bias in emergency medicine chart review studies. Ann Emerg Med. 2014;64(3):292–8.
Kokotailo RA, Hill MD. Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke. 2005;36(8):1776–81.
Bederson JB, Connolly ES Jr, Batjer HH, Dacey RG, Dion JE, Diringer MN, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council. Am Heart Assoc Stroke. 2009;40(3):994–1025.
Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1711–37.
Steiner T, Juvela S, Unterberg A, Jung C, Forsting M, Rinkel G; European Stroke Organization. European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35(2):93–112.
Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4(3):200–5.
Ganesh A, Luengo-Fernandez R, Wharton RM, Rothwell PM; Oxford Vascular Study. Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke. Neurology. 2018;91(21):e1951–60.
Thompson MP, Reeves M. Assessing the utility of the modified Rankin Scale (mRS) at discharge to predict day 90 outcomes in acute stroke registries [abstract]. Circ Cardiovasc Qual Outcomes. 2012;5(Suppl 1):A168.
Suwatcharangkoon S, De Marchis GM, Witsch J, Meyers E, Velazquez A, Falo C, et al. Medical treatment failure for symptomatic vasospasm after subarachnoid hemorrhage threatens long-term outcome. Stroke. 2019;50(7):1696–702.
Aaslid R, Huber P, Nornes H. Evaluation of cerebrovascular spasm with transcranial Doppler ultrasound. J Neurosurg. 1984;60(1):37–41.
Lindegaard KF. The role of transcranial doppler in the management of patients with subarachnoid haemorrhage—a review. Acta Neurochir Suppl. 1999;72:59–71.
Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77(6):848–52.
Bracard S, Lebedinsky A, Anxionnat R, Neto JM, Audibert G, Long Y, et al. Endovascular treatment of Hunt and Hess grade IV and V aneuryms. AJNR Am J Neuroradiol. 2002;23(6):953–7.
Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;304(7872):81–4.
Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28(1):14–20.
Bushinsky DA, Monk RD. Calcium. Lancet. 1998;352(9124):306–11.
Bilkovski RN, Cannon CM, Adhikari S, Nasr I. Arterial and venous ionized calcium measurements: Is there a difference? [abstract]. Ann Emerg Med. 2004;44(4 Suppl):S56.
Kutner MH, Nachtsheim CJ, Neter J, Li W. Applied linear statistical models. 5th ed. New York: McGraw-Hill/Irwin; 2004.
Can A, Rudy RF, Castro VM, Dligach D, Finan S, Yu S, et al. Low serum calcium and magnesium levels and rupture of intracranial aneurysms. Stroke. 2018;49(7):1747–50.
James MFM, Roche AM. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth. 2004;18(5):581–6.
Ho KM, Yip CB. Concentration-dependent effect of hypocalcaemia on in vitro clot strength in patients at risk of bleeding: a retrospective cohort study. Transfus Med. 2016;26(1):57–62.
Magnotti LJ, Bradburn EH, Webb DL, Berry SD, Fischer PE, Zarzaur BL, et al. Admission ionized calcium levels predict the need for multiple transfusions: a prospective study of 591 critically ill trauma patients. J Trauma. 2011;70(2):391–5; discussion 395–7.
Ditzel RM, Anderson JL, Eisenhart WJ, Rankin CJ, DeFeo DR, Oak S, et al. A review of transfusion- and trauma-induced hypocalcemia. is it time to change the lethal triad to the lethal diamond? J Trauma Acute Care Surg. 2020;88(3):434–9.
Jartti P, Karttunen A, Jartti A, Ukkola V, Sajanti J, Pyhtinen J. Factors related to acute hydrocephalus after subarachnoid hemorrhage. Acta Radiol. 2004;45(3):333–9.
Mupanomunda MM, Ishioka N, Bukoski RD. Interstitial Ca2+ undergoes dynamic changes sufficient to stimulate nerve-dependent Ca2+-induced relaxation. Am J Physiol. 1999;276(3):H1035–42.
Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35(6):1364–7.
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636–42.
Welling LC, Welling MS, Figueiredo EG. Hypocalcemia and intracerebral hemorrhage: association or causality? World Neurosurg. 2017;97:718–9.
Aberegg SK. Ionized calcium in the ICU should it be measured and corrected? Chest. 2016;149(3):846–55.
Vasudeva M, Mathew JK, Fitzgerald MC, Cheung Z, Mitra B. Hypocalcaemia and traumatic coagulopathy: an observational analysis. Vox Sang. 2020;115(2):189–95.
Vinas-Rios JM, Sanchez-Aguilar M, Sanchez-Rodriguez JJ, Gonzalez-Aguirre D, Heinen C, Meyer F, et al. Hypocalcaemia as a prognostic factor of early mortality in moderate and severe traumatic brain injury. Neurol Res. 2014;36(2):102–6.
Vinas-Rio JM, Sanchez-Aguilar M, Sanchez-Rodriguez JJ, Muruato-Araiza LF, Meyer F, Kretschmer T, et al. Hypocalcemia as a prognostic factor in mortality and morbidity in moderate and severe traumatic brain injury. Asian J Neurosurg. 2015;10(3):190–4.
Author information
Authors and Affiliations
Contributions
DE conceived the idea for the study, designed the study, collected and analyzed the data, performed the statistical analysis, drafted the manuscript, and approved the final manuscript as submitted; YF conceived the idea for the study, designed the study, collected and analyzed the data, drafted the manuscript, and approved the final manuscript as submitted. Contributed equally as first author. EM conceived the idea for the study, critically reviewed the manuscript, and approved the final manuscript as submitted; TD conceived the idea for the study, analyzed the data, critically reviewed the manuscript, and approved the final manuscript as submitted; EK collected and analyzed the data, drafted the manuscript, and approved the final manuscript as submitted; AR conceived the idea for the study, designed the study, critically reviewed the manuscript, and approved the final manuscript as submitted; AN conceived the idea for the study, designed the study, drafted the manuscript, critically reviewed the final version of the manuscript, and approved the final manuscript as submitted; AM conceived the idea for the study, designed the study, critically reviewed the manuscript, and approved the final manuscript as submitted.
Corresponding author
Ethics declarations
Conflict of interests
AR is a consultant for Medtronic and is supported by the United States–Israel Binational Science Foundation (not related to this study). All the other authors declare no conflicts interest.
Ethical Approval/Informed Consent
The study was performed in concordance with the Helsinki declaration and was approved by the Institutional Review Board at Rambam Health Care Campus (approval number RMB-0181-20). The need for written informed consent was waived because of the retrospective study design.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Epstein, D., Freund, Y., Marcusohn, E. et al. Association Between Ionized Calcium Level and Neurological Outcome in Endovascularly Treated Patients with Spontaneous Subarachnoid Hemorrhage: A Retrospective Cohort Study. Neurocrit Care 35, 723–737 (2021). https://doi.org/10.1007/s12028-021-01214-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-021-01214-3